Breast Cancer Overdiagnosis Risk Lower Than Feared

A comprehensive review of breast cancer screening data indicates that overdiagnosis, where harmless tumors are treated unnecessarily, affects fewer than 5% of screenings. This figure is substantially lower than prior estimates, which had suggested that as many as 30% to 50% of detected breast cancers might represent overdiagnosis. The research team suggests that earlier studies may have been inaccurate due to limited follow-up periods.

By analyzing data from eight randomized controlled trials and long-term Danish screening records, researchers concluded that previous high estimates of overdiagnosis were based on immature trial data. They found that apparent overdiagnosis was often simply the early detection of cancers that would eventually have been diagnosed. This new evaluation seeks to provide a more realistic understanding of screening outcomes and reassure women invited for mammograms.